4//SEC Filing
Adaptimmune Therapeutics PLC 4
Accession 0001104659-17-043262
$ADAPCIK 0001621227operating
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 5:01 PM ET
Size
5.5 KB
Accession
0001104659-17-043262
Insider Transaction Report
Form 4
Kerr Giles Francis Bertram
Director
Transactions
- Award
Option to purchase Ordinary Shares
2017-07-03+144,000→ 144,000 totalExercise: $0.75From: 2018-07-03Exp: 2027-07-03→ Ordinary Shares (144,000 underlying)
Footnotes (1)
- [F1]The exercise price was converted from GBP0.58 based on the closing midpoint exchange rate for the U.S. dollar on the trading day prior to the date of grant listed in the Financial Times. The actual exercise price will be the pounds sterling amount.
Documents
Issuer
Adaptimmune Therapeutics PLC
CIK 0001621227
Entity typeoperating
IncorporatedUnited Kingdom
Related Parties
1- filerCIK 0001621227
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 5:01 PM ET
- Size
- 5.5 KB